平消胶囊联合FOLFIRI化疗方案治疗晚期大肠癌的疗效观察
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:观察平消胶囊联合FOLFIRI化疗方案(CPT-11+5-FU+CF)治疗晚期结直肠癌的疗效及毒副反应。方法:自2008年5月至2010年02月在新疆维吾尔自治区中医院肿瘤科住院病例,选应用平消胶囊联合FOLFIRI化疗方案治疗晚期结直肠癌患者33例与单纯行FOLFIRI化疗方案的晚期结直肠癌患者30例行随机对照试验。FOLFIRI化疗方案为:伊立替康(CPT-11)+5-氟尿嘧啶(5-FU)+亚叶酸钙(CF)。33例晚期结直肠癌患者自化疗之日起即口服平消胶囊(西安正大制药有限公司生产,0.23g/粒),口服,1.84g/粒,3次/日,IFL化疗方案的应用方法:伊立替康150mg/m2加入0.9%氯化纳注射液250mL中静脉滴注,第1天;5-氟尿嘧啶400mg/m2静脉推注,再用5-氟尿嘧啶600mg/m2通过全自动注药泵持续静脉输注22h,第1、2天;亚叶酸钙200mg/m2加入5%葡萄糖注射液250mL中静脉滴注,第1、2天。14d为1个周期,2周期为1个疗程。治疗前后观察患者食欲、疼痛缓解情况、疲乏改善程度,以及血常规、肝肾功及心电图等相关检查指标的变化情况。结果:平消胶囊联合FOLFIRI化疗可改善大肠癌患者部分临床症状,缓解疲乏状态,提高生活质量,并减轻血液和消化系统毒副反应,与对照组相比,P<0.05,有统计学意义,两组对肝、肾功能的损害不明显,P>0.05,无统计学意义。结论:平消胶囊作为纯中药制剂,有活血化瘀、散结止痛、扶正祛邪、清热解毒之功效,且联合FOLFIRI化疗方案作为治疗组在治疗晚期结直肠癌时在一定程度上能够提高化疗疗效,并能保护和促进骨髓造血功能,减轻血液学毒性,值得临床应用。
Objective:To observe the effect and toxicity of the regimen of Pingxiao capsule combined with chemotherapy scheme of FOLFIRI for the treatment of advanced colorectal Cancer. Methods:Choosing the patients be hospitalized in our hospital between May,2008 and February,2010. Pingxiao capsule plus chemotherapy scheme of FOLFIRI was applied to treat 33 cases of advanced colorectal Cancer and choosing 30 patients for the only chemotherapy scheme of FOLFIRI. chemotherapy scheme of FOLFIRI include:CPT-11 150mg/m2 and 0.9% NaCl 250 mL ivgtt d1 5-FU 400 mg/m2 iv bolus,Following 5-FU 600 mg/m2 ivgtt 22h d1,d2;CF 200 mg/m2 and 5% GS 250mL ivgtt 2h d1,d2;two weeks as one cycle,efficacy and toxicity were evaluated at three cycles. When beginning the chemotherapy scheme of FOLFIRI,the group of curing patients take the medicine of Pingxiao capsule until the treatment being end. In front and behind,to observe the situation of the,appetite,extent of pain and tiring,the target of liver and kidney function,blood routine,ECG. Results:After two periods of treatment,the subjective symptoms、KPS、weights、the tumor mark(CEA)were significantly improved in the treated group,better than in the control one. In the sides of curative effect and quality of living,even the degree of alimentary canal side-effect and hematology toxicity in treatment group were better than the control group,P<0.05. But there was no difference between two groups on the size of focus,the toxicity occurent rate and toxic degree ware slighter in the treated group than in the control one,P>0.05.Conclusion:Pingxiao capsule combined with chemotherapy for the treatment of advanced colorectal Cancer can alleviate the alimentary cancal side-effect and hematology toxicity of chemotherapy drug in treating gastric cardia carcinoma.In all,it is effective and tolerable in advanced colorectal cancer. It is good for generalizing.
引文
[1]郑树.结直肠肿瘤—基础研究与临床实践[M].北京:人民卫生版社, 2006: 3-4.
    [2]李文煜.大肠癌诊治进展[J].中国中西医结合外科杂志, 2003, 9: 334-335.
    [3]胡文蔚,王赫,孙文辉.伊立替康联合氟尿嘧啶亚叶酸钙治疗转移性大肠癌31例临床观察[J].中国癌症杂志, 2008, 18 (01) : 77.
    [4]刘非,刘健.平消胶囊治疗恶性肿瘤研究概况.现代肿瘤医学, 2007, 15 (01) : 142.
    [5]汤钊猷.现代肿瘤学[M].上海医科大学出版社. 1993: 434.
    [6]赵文硕,张青,王笑民.大肠癌的中医诊疗现状[J].中国中医药信息杂志, 2008, (11) : 103.
    [7]刘冬兰,齐淑轶,邓觐云.依利替康联合5-氟尿嘧啶?亚叶酸钙治疗晚期大肠癌[J].江西医学院学报, 2008, 48 (01) : 59.
    [8] ContiJA, KemenyNE, SaltzLB, etal. Irinotecan is an active agent in ntreated patients with metastatic colorectal cancer[J]. J. Clin Oncol, 1996, 14 (03) : 709.
    [9]张覃沐.抗肿瘤药物的药理与临床应用[M].河南:河南医科大学出版社, 1999: 220.
    [10]GoldwasserF, ShimizuT, JackmanJ, etal. Correlations between S and G2 arrest and the cytotoxicity of Camptot hecin in human colon Carcinoma cells[J]. Cancer Res, 1996, 56 (19) : 4430.
    [11]刘亚娴.中西医结合肿瘤病学[M]. 2005,第3版,北京:中国中医药出版社, 2005: 147-150.
    [12]高剑鸣,吴勉华.中药治疗大肠癌研究进展[J].实用中医内科杂志, 2008, (04) .
    [13]陈捷,李增战,杨晨光等.平消胶囊联合化疗治疗66例胃癌的临床研究[J].现代肿瘤医学, 2007, 15 (1) : 65.
    [14]周岱翰.临床中医肿瘤学[M].北京:人民卫生出版社, 2003: 575.
    [15]张学莉,叶正宝,丁国瑾,等.化疗方案联合平消胶囊治疗晚期胃癌疗效观察[J].现代中西医结合杂志, 2004, 13 (4) : 21.
    [16]张德勋,孙晓东,袁秉祥,等.平消胶囊对小鼠包膜下移植人肺癌瘤体生长的影响[J].现代肿瘤医学, 2003, 11 (3) : 174-175.
    [17]段萍.癌痛的三阶梯止痛疗法临床疗效分析[J].四川肿瘤防治, 2000, 13 (02) : 104.
    [18]牛桂珍.平消胶囊治疗肺癌40例疗效观察[J].中国医药指南, 2007, 3: 125.
    [19]王凤英,孙菁.平消胶囊治疗恶性肿瘤疗效及其对放疗增敏的初步研究[J].陕西肿瘤医学, 2000, 8 (2) : 81-3.
    [20]Wang YQ, Wada A, Ugai S. Exrepression of the MIG (CXCL9) gene in murine lung caicinoma cells generated angiogenesis-independent anti-tumor effects[J]. Oncol Rep, 2003, 10 (4) : 909-13.
    [21]朱庆贵.平消胶囊抗癌的分子生物学机制[J].南方医科大学学报, 2008, 28 (11) : 2069-2070.
    [22]董瑞琴,邱月花,郭艳.平消胶囊治疗晚期乳腺癌48例临床分析[M].西安:平消胶囊治疗妇科肿瘤及乳腺病论文汇编(西安正大有限公司编) , 2003. 13-14.
    [23]方建龙,赵安兰,朱智斌,等.平消胶囊治疗晚期恶性肿瘤278例临床观察[J].现代肿瘤医学, 2003, 11 (4) : 309-310.
    [24]倪爱娣,来家和,周荣耀.平消胶囊配合化疗对肿瘤疗效及免疫指标观察[J].上海中医杂志, 2000, 7: 15-16.
    [25]中华人民共和国卫生部编.中药新药临床研究指导原则[M].第三辑. 1997: 6.
    [26]方建龙,赵安兰,朱智武,等.平消胶囊治疗晚期恶性肿瘤27例临床观察[J].现代肿瘤医学, 2003, 11 (4) : 309-310.
    [27]中华人民共和国卫生部医政司编.中国常见恶性肿瘤诊治规范(第9分册) [M].北京:北京医科大学,中国协和医科大学联合出版社, 1999: 10.
    [28]方建龙,赵安兰,朱智武,等.平消胶囊治疗晚期恶性肿瘤278例临床观察[J].现代肿瘤医学, 2003, 11 (4) : 309-310.
    [1]钟毅,周红,张卫萍,江俊珊.辨证治疗癌痛54例[J].江西中医药, 2001, 32 (5) : 14.
    [2]陈世伟,张利民.肿瘤中西医综合治疗[M].北京:人民卫生出版社, 2001: 195.
    [3]杨柳.癌性疼痛的中药治疗. CHINESE JOURNAL OF PRIMARY MEDICINE, 1998, 5 (5) : 301.
    [4]彭海燕,章永红,王瑞平,蔡明明.消痛方治疗癌性疼痛的临床观察[J].四川中医, 2003, 21 (12) : 46.
    [5]付烊,运强.身痛逐瘀汤结合唑来膦酸治疗骨转移癌痛疗效观察[J].光明中医. 2008, 23 (01) : 48.
    [6]吴健,朱学明,方卫东.中医药治疗癌症疼痛42例[J].光明中医, 2000, 15 (86) : 29.
    [7]任华萍.血府逐瘀汤加味治疗晚期癌症疼痛38例[J].中医研究, 2002, 15 (1) : 40.
    [8]陈德货.定痛汤加味治疗癌性疼痛45例[J].湖北中医杂志, 2002, 24 (2) : 33.
    [9]赵富兰,卢一飞.全蝎罂粟壳汤治疗晚期癌症疼痛30例[J].内蒙古中医药, 1997: 12.
    [10]孙金芳,芦连菊,臧建华,荆振海.痛舒膏外敷治疗癌性疼痛临床观察[J]. Chinese Journal of Information on TCM, 2006, 13 (1) : 56.
    [11]宋耀鸿,夏卫军.化癌镇痛膏治疗癌症疼痛31例临床观察[J].江苏中医药, 2002, 23 (4) : 20.
    [12]万冬桂,李佩文.痛块消巴布膏剂治疗癌症疼痛的临床研究[J]. Chinese Journal of nformation on TCM, 2005, 12 (10) : 68.
    [13]倪依群,林苏.消症膏治疗晚期胰腺癌疼痛24例[J].辽宁中医杂志, 2008, 35 (01) : 60.
    [14]杨晨光.癌症止痛贴治疗癌性疼痛30例[J].陕西中医, 2007, 28 (5) : 521.
    [15]高炜,徐艳霞,徐媺.芬太尼透皮贴治疗中重度癌痛52例[J].中国乡村医药杂志, 2008, 15 (07) : 24.
    [16]罗蕾,向明芳.多瑞吉贴剂治疗老年癌性疼痛的观察与护理[J].现代护理, 2008, 14 (06) : 825.
    [17]李道乾.癌痛消涂剂治疗癌性疼痛100例[J].中国中医药信息杂志, 2001, 08 (10) : 52.
    [18]杨瑞利,曲培莲.中药局部外搽治疗癌性疼痛[J]. China Journal Of Cancer Prevention And Treatment, 2000, 07 (02) : 174.
    [19]秦飞虎,秦宇航.按灸疗法治疗原发性肝癌疼痛36例[J].中国针灸, 2001, 21 (09) :540.
    [20]苏寅,李荣.辨证穴贴治疗骨转移癌疼痛临床观察[J].中国中医骨伤科杂志, 2003, 11 (5) : 46.
    [21]管钟洁.耳穴注射治疗胰腺癌疼痛案[J].中国针灸, 2001, 21 (1) : 40.
    [22]王秀香.针灸镇痛治疗晚期癌症疼痛[J].实用医药杂志, 2007, 24 (12) : 1458.
    [23]徐淑英,徐满英.癌性腹痛应用针刺足三里穴镇痛临床观察[J].实用中西医结合杂志, 1994, 07 (01) : 22.
    [24]孙亚林,于连荣.齐刺针法治疗肝癌疼痛80例疗效观察[J].中国针灸, 2000, 4. 211.
    [25]高瞻,徐小煌,饶本强,等.针灸加癌痛定液外用治疗癌性疼痛疗效观察[J].实用中医药杂志, 1998, 11. 7.
    [26]丹宇,梁亚兵,陶治.针刺对癌症疼痛镇痛作用的临床研究[J].中国针灸, 1998, 1 (18) : 17.
    [27]牛红梅.癌痛欣滴鼻剂治疗癌痛的临床与实验研究[J].山东中医药大学学报, 1999, 23 (06) : 430.
    [28]王瑞平等.辛香止痛剂治疗癌性疼痛疗效观察[J].中医研究, 1997, 10 (3) : 37.
    [29]张立培等.哭来笑去散经鼻粘膜给药治疗癌性疼痛[J].河南中医, 1998, 18 (02) : 10.
    [30]刘如瀚.手拈散加味保留灌肠治疗胃癌疼痛[J].江西中医药, 1995. 103.
    [31]黄兆明.中药灌肠综合治疗癌性肠梗阻临床观察[J].实用中西医结合临杂志, 2003, 3 (3) : 36.
    [32]许春明,顾红芳,丁令池,卫国华.中药灌肠加针灸治疗癌性肠梗阻56例[J].南京中医药大学, 2008, 24 (6) : 419.
    [33]郭彦伟,张晓勇,潘晓红.复方苦参注射液治疗轻中度癌痛的疗效观察[J].医学伦理与实践, 2005, 18 (2) : 165.
    [34]杨焕彪.肿节风注射液治疗癌性疼痛60例[J].传统医药, 2008, 17 (20) .
    [35]张明东,曲立贞.复方苦参注射液治疗癌痛46例临床观察[J]. Journanl of Basic And Clinical Oncology, 2008, 21 (02) : 170.
    [36]赵新萍,李玫,鲁保风.甘露醇治疗癌痛的临床观察[J].临床医药实践杂志, 2008, 17 (01) : 33.